Compositions and methods for treating and preventing hepatitis b and d
Номер патента: EP4376881A1
Опубликовано: 05-06-2024
Автор(ы): Lars Frelin, Matti Sallberg, Nico Mertens
Принадлежит: Svenska Vaccinfabriken Produktion Ab
Опубликовано: 05-06-2024
Автор(ы): Lars Frelin, Matti Sallberg, Nico Mertens
Принадлежит: Svenska Vaccinfabriken Produktion Ab
Реферат: Disclosed herein are immunogenic compositions or product combinations of engineered hepatitis B and hepatitis D nucleic acids, genes, peptides, or proteins that can be used to elicit an immune response against a hepatitis B and/or hepatitis D infection. Also disclosed are methods of using the immunogenic compositions or product combinations in subjects to generate immune responses against HBV and/or HDV by administering the compositions or combinations, for example, with a nucleic acid prime and polypeptide boost approach.
Combinations of viral proteins, peptide sequences, epitopes, and methods and uses thereof
Номер патента: US20240239844A1. Автор: Erica Ollmann SAPHIRE,Haoyng LI. Владелец: La Jolla Institute for Allergy and Immunology. Дата публикации: 2024-07-18.